EFFICACY OF NON-INVASIVE TREATMENT OF UTERINE FIBROID-ASSOCIATED BLEEDING IN WOMEN OF REPRODUCTIVE AGE

This study was conducted to evaluate the effectiveness of non-invasive conservative treatment of myoma-associated uterine bleeding in women of reproductive age with uterine fibroids at the Urogynecology and Polyclinic Departments of the Multidisciplinary Clinic of Samarkand State Medical University. A total of 50 patients were included in the study: 30 patients had abnormal uterine bleeding associated with uterine fibroids, while 20 patients had fibroids without bleeding. All patients underwent clinical and anamnestic assessment, gynecological examination, complete blood count, and ultrasound examination. In patients with bleeding, the duration and intensity of menstrual bleeding were assessed. Treatment was carried out using only non-invasive conservative methods, including hormonal therapy, antifibrinolytic and hemostatic agents, as well as iron supplements. According to the treatment outcomes, 23 out of 30 patients (76.7%) with bleeding demonstrated a clinically significant reduction in the volume and duration of menstrual bleeding. The average duration of menstruation decreased from 8.2 ± 1.4 days before treatment to 5.1 ± 1.2 days after treatment. The mean hemoglobin level increased from 98.6 ± 8.3 g/L to 112.4 ± 7.6 g/L. Among patients with non-bleeding uterine fibroids, clinical stability was maintained in 18 patients (90.0%) during the follow-up period. The obtained results indicate that non-invasive conservative methods demonstrate high clinical efficacy in the treatment of myoma-associated uterine bleeding and contribute to uterine preservation in women of reproductive age.

Hali tarjima qilinmagan